• Reported GAAP EPS of -$0.03 down -400.00% YoY • Reported revenue of $8.77M up 9.44% YoY • Health In Tech reiterated guidance for 2026 annual revenue ranging between $45M and $50M, representing year-over-year growth of approximately 35% to 50%.
Bullish
Health In Tech achieved 9.4% revenue growth to $8.8M and expanded its distribution partners by 29.5%. Its AI-driven platform offers a competitive advantage through rapid feature deployment.
Bearish
Health In Tech reported a net loss of $1.6M and negative adjusted EBITDA of -$1.3M, reflecting higher sales and marketing expenses and a decline in underwriting modeling revenue.